以脂质为基础的纳米载体的结构为中心的设计,以克服生物障碍
Yeeun Woo1, Jinwook Yoon1, Yoseph Seo1
1Department of Chemical Engineering, Kwangwoon University, 20 Gwangwoon-Ro, Nowon-Gu, Seoul, 01897, Republic of Korea.
Materials today. Bio
|November 10, 2025
概括
基于脂质的纳米载体 (LBNs) 已经在结构上进化,以克服药物输送中的生物障碍. 它们的设计进展,从简单的乳液到复杂的仿生结构,提高了治疗效率和安全性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 材料科学 材料科学 材料科学
背景情况:
- 药物输送系统 (DDS) 正在随着技术的发展而发展,以克服生物障碍.
- 纳米技术的整合导致了各种纳米级DDS.
- 关于纳米药物毒性的担忧已经将重点转移到更安全,生物相容的基于脂质的纳米载体 (LBNs).
研究的目的:
- 审查LBN的结构演变.
- 根据功能复杂性,将LBN结构发展分为三个阶段.
- 为了解LBN设计进步提供一个框架,以响应生理需求.
主要方法:
- 将LBN结构演变分为三个阶段的分类.
- 分析每个阶段使用的策略,包括脂质组成调整,表面功能化,仿生构造和杂交.
- 对最近的LBN研究策略进行了全面的讨论.
主要成果:
- LBN的结构演变被分为三个阶段,反映了越来越复杂的功能.
- 进步包括脂质组成调整,表面功能化,仿生方法和杂交.
- 渐进表明了由生物障碍驱动的逐步结构适应.
结论:
- LBNs的结构演变是克服生物障碍以改善药物输送的关键因素.
- 了解这种演变为改进LBN设计方法提供了基础.
- 优化的LBN设计有望提高治疗效果和安全性.
相关概念视频
01:27Bioavailability Enhancement: Drug Permeability Enhancement
179
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
179
01:24Cellular Membranes and Drug Transport
1.4K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.4K